Research and Clinical Trials

Brief Description  
The purpose of this study is to test the safety and effectiveness of the study drug sitagliptin (Januvia) in patients with type 2 diabetes and cardiovascular disease.
Who may be Eligible  
Men and women 50 years and older with a history of type 2 diabetes and cardiovascular disease.
IRB Number  
CHS1-09-318
Principal Investigator  
Dulin, Michael

For More Information, Contact  Kelry  R, Preston
Phone:  (704) 304-7145  Fax:  (704) 304-7102  
Email:  kelry.preston@carolinashealthcare.org
Address:2001 Vail Avenue Suite 400 Mercy Medical Plaza Charlotte, NC 28207
Close